TP53 and myelodysplastic syndrome: Reliance on the variant allele frequency of TP53 mutations above a threshold of 50%[3] or 55%[5] missed 12% of AML/MDS with multi-hit TP53 in this study, and up to 25% of MDS cases with CN-LOH in the previous study[4].